10x Genomics
TXG
TXG
252 hedge funds and large institutions have $3.91B invested in 10x Genomics in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 95 increasing their positions, 85 reducing their positions, and 91 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
34% less call options, than puts
Call options by funds: $13.9M | Put options by funds: $21.1M
38% less capital invested
Capital invested by funds: $6.29B → $3.91B (-$2.38B)
60% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 91
Holders
252
Holding in Top 10
8
Calls
$13.9M
Puts
$21.1M
Top Buyers
| 1 | +$119M | |
| 2 | +$115M | |
| 3 | +$93.7M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$46.3M |
| 5 |
JP Morgan Chase
New York
|
+$41.9M |
Top Sellers
| 1 | -$106M | |
| 2 | -$71.5M | |
| 3 | -$57.4M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$55.1M |
| 5 |
FAM
Fred Alger Management
New York
|
-$25M |